Company Overview of Novartis Consumer Health, Inc.
Novartis Consumer Health, Inc. creates, develops, and manufactures products that restore, maintain, and improve the health and well-being. It offers various over-the-counter products, including mineral supplements, topical antifungal agents, systemic and topical analgesic, antacids, anti inflammatory pain relief gel, and antifungal products; and products for cold sore treatment, overnight laxative, skin irritation treatment, adult gas relief, smoking cessation, nasal decongestant, adult cold and flu, skin care, and pediatric cough and cold. The company also provides contact lenses and lens care products. In addition, it involves in the research, development, and commercialization of pet and ...
200 Kimball Drive
Parsippany, NJ 07054-0622
Key Executives for Novartis Consumer Health, Inc.
Chief Executive Officer of Vaccines and Diagnostics
President of BioMedical Research
Head of Corporate Communications
Compensation as of Fiscal Year 2014.
Novartis Consumer Health, Inc. Key Developments
Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Novartis Consumer Health, Inc. Announces Voluntarily Recall of Select Lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups Manufactured in the United States Before December 2011
Jan 31 13
Novartis Consumer Health, Inc. announced that it is voluntarily recalling certain lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups that were manufactured in the United States before December 2011. The company has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the US because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place. The company received four adverse events related to this issue on bottles of Triaminic(R) Syrups. There were no reports of adverse events related to this specific issue for Theraflu Warming Relief(R) Syrups. Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups continue to be safe and effective when used as directed on the package label. The products being recalled were produced at the Novartis Consumer Health manufacturing facility in Lincoln, Nebraska prior to the voluntary suspension of operations and shipments at the facility in December 2011. A consumer complaint in the US in late November 2012 triggered an internal investigation by Novartis Consumer Health that determined a voluntary recall was in the best interest of consumers.
Endo Pharmaceuticals, Inc. and Novartis Consumer Health, Inc. Mutually Terminate Master Development and Toll Manufacturing Agreement
Jan 7 13
Effective as of December 31, 2012, Endo Pharmaceuticals, Inc. and Novartis Consumer Health, Inc. mutually terminated master development and toll manufacturing agreement dated May 3, 2001 between the parties. Pursuant to the manufacturing agreement, Novartis Consumer Health manufactured certain of Endo's commercial products and products in development. The manufacturing agreement was to terminate effective February 2014. The termination did not give rise to any early termination penalties.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|